Obesity

Don’t cheer the end of America’s obesity crisis just yet.

Cheskin, a George Mason Distinguished University Professor, has devoted his career to the research, treatment, and advocacy of obesity prevention and treatment.

Obesity Statistics and Facts In 2025

The associations of objective, behaviorally measured hunger and weight-related variables with Food Craving Inventory subscales in adults with obesity

Food noise: definition, measurement, and future research directions.

After Novo and Lilly resolved GLP-1 shortages, where does the compounding industry stand? Experts weigh in

Does Ozempic Shrink the Size of Your Hands?

The award is the highest achievement attainable for university faculty, representing outstanding contributions to research and scholarship in their field. 

After nearly three years of backorders and pharmacy scrambles, the high-demand weight-loss drugs Ozempic, Wegovy, and Mounjaro are finally back in full supply. The FDA recently declared an end to the nationwide shortage of their active ingredients, semaglutide and tirzepatide. Martin Binks, chair of the Department of Nutrition and Food Studies at George Mason University and a researcher and clinician with expertise in obesity, explains what this moment means for patients, providers, and public health.

Yes, college students gain holiday weight too—but in the form of muscle, not fat.